title: Cystic fibrosis: an update for clinicians. Part 2: hepatobiliary and pancreatic manifestations.
abstract: This paper, the second in the series, will build on the first and explore the importance of liver and pancreatic manifestations of cystic fibrosis (CF) and the effect on morbidity and mortality of this multifaceted genetic condition. It will also further develop the critical role of the gastroenterologist as part of the multidisciplinary group of clinicians and allied health staff in the effective management of patients with CF.
authors.affiliation: Department of Gastroenterology and Clinical Nutrition, Royal Children's Hospital Parkville, Melbourne, Victoria.
authors.forename: Oren
authors.initials: O
authors.lastname: Ledder
authors.forename: Wolfram
authors.initials: W
authors.lastname: Haller
authors.forename: Richard Tl
authors.initials: RT
authors.lastname: Couper
authors.forename: Peter
authors.initials: P
authors.lastname: Lewindon
authors.forename: Mark
authors.initials: M
authors.lastname: Oliver
mesh_terms: D001660:Biliary Tract Diseases / Q000209:etiology; D003550:Cystic Fibrosis / Q000175:diagnosis / Q000209:etiology; D003920:Diabetes Mellitus / Q000209:etiology; D010188:Exocrine Pancreatic Insufficiency / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D005500:Follow-Up Studies; D006801:Humans; D008107:Liver Diseases / Q000209:etiology; D010195:Pancreatitis / Q000209:etiology
keywords: cirrhosis; cystic fibrosis; liver; nutrition; pancreas; pancreatic enzymes